Neurogene News and Activities

Presence

Neurogene develops genetic medicines for serious neurological disorders. Its products and services include gene therapy programs, research services, and clinical development for patients, healthcare providers, and research partners.

Neurogene products and services overview:

Gene therapies
Neurology treatments
Clinical development
Research services

Revenue: ~$2 million

Employees: 130

Headquarters: New York, United States (USA)

Neurogene is one of the...

Neurogene is a company listed under the stock ticker NGNE (US).

Executives

View the org chart displaying its 23 main executives

Most searched biographies at Neurogene

Popular executive movements at Neurogene

Joseph Dossantos has joined the company as Senior Vice President, Finance (posted on May 30 2026).
Christy Shafer has joined the company as Chief Commercial Officer (posted on April 21 2026).
Christine Mikail who was Chief Financial Officer and Chief Business Officer, becomes Chief Financial Officer and Chief Business Officer and Director (posted on April 21 2026).

Create your alert
to follow the executive moves at Neurogene.